These injections are effective for sustainable weight loss, but they are not suitable for everyone
Lancet Gastroenterol Hepatol 2(12):890899 Halim MA, Degerblad M, Sundbom M, Karlbom U, Holst JJ, Webb D-L et al (2018) Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans
Implications for pharma marketers: Inexpensive generic versions of Ozempic and Wegovy outside the US don't just erode brands' global revenue, but also reset expectations about costs for this class of drugs
Diabetes (1995) 44:12028
Managing Treatment Costs Managing the costs associated with GLP-1 treatments involves strategic planning and transparent partnerships
reported metastasis in 67 of 175 patients, either at the time of presentation or in follow-up, with the lung being the most common site (55%), followed by intra-abdominal visceral and osseous metastases [3]